title: Adjuvant docetaxel plus doxorubicin and cyclophosphamide increases survival compared with fluorouracil plus doxorubicin and cyclophosphamide in women with operable node-positive breast cancer.
authors.affiliation: Mayo Clinic Jacksonville, Jacksonville, FL, USA.
authors.forename: Vivek
authors.initials: V
authors.lastname: Roy
authors.forename: Edith A
authors.initials: EA
authors.lastname: Perez